openPR Logo
Press release

Amyotrophic Lateral Sclerosis Treatment Market to Witness Growth Acceleration by 2030

04-03-2024 04:59 PM CET | Health & Medicine

Press release from: Orion Market Research

Amyotrophic Lateral Sclerosis Treatment Market to Witness

Global amyotrophic lateral sclerosis treatment market is anticipated to showcase a considerable CAGR during the forecast period. Amyotrophic lateral sclerosis disease is considered to be a disease of aging. People above the age of 65 are highly susceptible to the amyotrophic lateral sclerosis disease. According to the World Health Organization (WHO), the geriatric population is expected to get double by 2050, when compared to 2000. Globally, in 2000, the proportion of the people aged over 65 years were 11.0% of the global population, and these statistics are expected to reach 22.0% by 2050. In turn, the geriatric population is expected to reach 2 billion by 2050, as compared to 605 million in 2010.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/amyotrophic-lateral-sclerosis-treatment-market

Similarly, the people aged over 80 years or older are expected to get quadrupled to 395 million from 2000 to 2050. According to the UN, over the next 15 years, the older population is expected to grow fastest in the Caribbean and Latin America with a projected 71.0% increase in the population aged 60 years or over, followed by Asia (66.0%), Africa (64.0%), Oceania (47.0%), Northern America (41.0%), and Europe (23.0%). In 2018, the global average geriatric population was 8.92%, in which, the percentage of geriatric population in developed economies was much higher than that of the global average (8.92%). In 2018, among the total population, the geriatric population accounted for 16.0% in North America, 22.0% in Germany, 23.0% in Italy, and 27.0% in Japan, among others.

The increasing prevalence of amyotrophic lateral sclerosis disorder along with the growing geriatric population which is more susceptible to this kind of disorders are expected to be key factors promoting the growth of the global amyotrophic lateral sclerosis treatment market. Mitsubishi Tanabe Pharma Corp., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., CORESTEM, Inc., BrainStorm Cell Ltd., Otsuka Pharmaceutical Co., Ltd., AB Science, Ionis Pharmaceuticals, Inc., Biohaven Pharmaceutical Holding Company Ltd., and so on are the key players operating in the global amyotrophic lateral sclerosis treatment industry.

Recent Development in Amyotrophic Lateral Sclerosis Treatment Market

In September 2018, ITF Pharma, a US-based pharmaceutical company had received the US FDA approval for TIGLUTIK (riluzole). The TIGLUTIK (riluzole) is an oral suspension for the treatment of amyotrophic lateral sclerosis. TIGLUTIK is the first and only easy-to-swallow thickened riluzole liquid for treatment of amyotrophic lateral sclerosis and is advised to intake twice daily via an oral syringe.

Global Amyotrophic Lateral Sclerosis Market Segmentation

By Type

• Medication
• Stem Cell Therapy
• Others

A full report of Amyotrophic Lateral Sclerosis Treatment Market is available at: https://www.omrglobal.com/industry-reports/amyotrophic-lateral-sclerosis-treatment-market

Global Amyotrophic Lateral Sclerosis Market - Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• AB Science
• Ascend Laboratories LLC
• Biogen Inc.
• Biohaven Pharmaceutical Holding Company Ltd.
• BrainStorm Cell Ltd.
• CORESTEM, Inc
• Hoffmann-La Roche AG
• Ionis Pharmaceuticals, Inc.
• ITF Pharma
• Mitsubishi Tanabe Pharma Corp.
• Mylan N.V.

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.


Visit more report at

https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/

https://www.linkedin.com/pulse/aesthetic-threads-market-increasing-demand-growth-2031-vishwakarma-pyg5f

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Amyotrophic Lateral Sclerosis Treatment Market to Witness Growth Acceleration by 2030 here

News-ID: 3450962 • Views:

More Releases from Orion Market Research

Eggshell Membrane Market Set to Witness Significant Growth by 2033 | Eggnovations LLC (US), Park Premium Ingredients (US)
Eggshell Membrane Market Set to Witness Significant Growth by 2033 | Eggnovation …
The global Eggshell Membrane Market was valued at approximately USD 173.78 million in 2024, and is projected to reach USD 396.55 million by 2033, growing at a compound annual growth rate (CAGR) of 9.6% from 2025 to 2033. Eggshell Membrane Market Overview The Eggshell Membrane Market is experiencing significant growth, driven by increasing consumer awareness of its health benefits, particularly in joint health and skin care. This natural biopolymer, rich in proteins
Printable Solar Cells Market Set to Witness Significant Growth by 2033 | Armor Group, Dyesol Ltd (Greatcell Solar), Eight19 Ltd, Toshiba Corporation
Printable Solar Cells Market Set to Witness Significant Growth by 2033 | Armor G …
The global Printable Solar Cells Market was valued at approximately USD 1.2 billion in 2024, and is projected to reach USD 4.8 billion by 2033, exhibiting a strong compound annual growth rate (CAGR) of 16.7% from 2025 to 2033. Printable Solar Cells Market Overview The Printable Solar Cells Market is on a rapid upward trajectory, led by rising demand for flexible, lightweight, and cost-effective energy solutions. Printable photovoltaic technologies-including organic, perovskite,
Sales Enablement Software Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Sales Enablement Software Market Size Analysis, Competitive Insights, Leading Pl …
The Sales Enablement Software Market was valued at approximately USD 3.4 billion in 2024 and is projected to reach around USD 13.1 billion by 2033, growing at a compound annual growth rate (CAGR) of 14.7% from 2025 to 2033. Sales Enablement Software Market Overview The Sales Enablement Software Market is experiencing significant growth, driven by the increasing need for businesses to enhance their sales processes and improve team performance. These platforms
Feed management software Market Set to Witness Significant Growth by 2033 | Prairie Systems, Dairy Records Management Systems (DRMS)
Feed management software Market Set to Witness Significant Growth by 2033 | Prai …
The global Feed Management Software Market was estimated to be around USD 0.6 billion in 2024, and is projected to reach approximately USD 1.2 billion by 2033, growing at a compound annual growth rate (CAGR) of about 7.5% from 2025 to 2033. Feed Management Software Market Overview The Feed Management Software Market is expanding steadily as the agriculture and livestock industries shift toward digital transformation to optimize feed formulation and reduce

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the